Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...
Factors like cold, dry weather, an immune system response, oily skin, and using alcohol-based lotions also contribute. A history of other skin disorders, including rosacea, psoriasis, and acne, may ...
Complete enrollment in its DMT310 Phase 3 STAR-1 clinical trial in moderate-to-severe acne. Dermata expects to complete enrollment in the STAR-1 study by the end of 2024 and plans to announce topline ...